Skip to main content
S 2477 116th Congress Senate Health Advisory bodies Congressional oversight Government studies and investigations Health programs administration and funding Health promotion and preventive care Medical research Medical tests and diagnostic methods Musculoskeletal and skin diseases Organ and tissue donation and transplantation Research administration and funding Research and development

National Commission on Scleroderma and Fibrotic Diseases Act of 2019

Introduced: September 12, 2019 Introduced by: Gillibrand, Kirsten E. Democratic · New York See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 12, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sep 12, 2019
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

National Commission on Scleroderma and Fibrotic Diseases Act of 2019

This bill temporarily establishes a National Commission on Fibrotic Diseases within the National Institutes of Health that must recommend improvements regarding fibrosis and fibrotic disease research.

What's happening now September 12, 2019

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 1
  • HR 3446 Related bill National Commission on Scleroderma and Fibrotic Diseases Act of 2019
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 4
All 4 Democratic 3 Republican 1
D
Booker, Cory A.
New Jersey · Dec 7, 2020
 D
Van Hollen, Chris
Maryland · Dec 7, 2020
 D
Schumer, Charles E.
New York · Oct 15, 2019
 R
Collins, Susan M.
Maine · Sep 26, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2477: National Commission on Scleroderma and Fibrotic Diseases Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-S-2477/
MLA
"S. 2477: National Commission on Scleroderma and Fibrotic Diseases Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-2477/.
Bluebook (legal)
S. 2477, 116th Cong. (2026), https://openamerica.io/bill/116-S-2477/.
Markdown link
[S. 2477: National Commission on Scleroderma and Fibrotic Diseases Act of 2019](https://openamerica.io/bill/116-S-2477/)
Report a problem